< Back to all clusters
[HEALTH] · Brazil · 50 sources

started · updated

Brazil to provide weight-loss medications through SUS

President Luiz Inácio Lula da Silva has announced that weight-loss medications, specifically GLP-1 receptor agonists like semaglutide, will be made available for free through Brazil’s Unified Health System (SUS). The initiative aims to provide responsible treatment for obesity rather than serving as an aesthetic tool.

Health Minister Alexandre Padilha stated that the distribution will follow strict clinical protocols and medical prescriptions. Priority will be given to patients with severe obesity, those on waiting lists for bariatric surgery, and individuals with associated comorbidities such as heart disease or a history of breast cancer.

The Ministry of Health is currently conducting a pilot study known as Real-Bari at the Grupo Hospitalar Conceição in Porto Alegre, monitoring 250 patients to establish safety guidelines and clinical effectiveness. Before a national rollout, the government must complete several steps, including evaluation by the National Commission for the Incorporation of Technologies in the SUS (Conitec), defining a specific public policy, and securing budgetary resources.

President Lula also cautioned against the indiscriminate prescription of these medications, emphasizing that treatment should be paired with physical activity and dietary changes.

Entities

Alexandre Padilha · Eurofarma · Grupo Hospitalar Conceição · Luiz Inácio Lula da Silva · Marília Arraes · Ministry of Health · Ministério da Saúde · Montes Claros · SUS · Sistema Único de Saúde · Unified Health System

Claims

What the coverage asserts, and how many sources carry each claim.

Sources

10 days ago